Carillon Chartwell Mid Cap Value Fund Q4 2025 Commentary [Seeking Alpha]
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: Seeking Alpha
The summer's short squeeze, which boosted low-quality stocks, continued in the fourth quarter as speculative fever began to break. Globus Medical reported stronger growth in sales of its core spine products and margin expansion from synergies, raising guidance to signal confidence in its sustained momentum. FMC's share price was pressured by concerns about accelerating loss of market share and mounting pricing pressure from generic competitors in its core diamide portfolio. The Fund's current positioning reflects a bottom-up process with modest overweights in the industrials, healthcare, and materials sectors and modest underweights in financials and information technology. Tippapatt/iStock via Getty Images Market Overview The summer's short squeeze, which boosted low-quality stocks, continued in the fourth quarter. The UBS High Short Interest Index rose more than 25% during the first two weeks of the quarter while major stock market averages barely This article was wri
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Globus Medical (GMED) had its price target raised by Wells Fargo & Company from $98.00 to $104.00. They now have an "overweight" rating on the stock.MarketBeat
- Globus Medical (GMED) was given a new $115.00 price target by Truist Financial Corporation.MarketBeat
- Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.MarketBeat
- Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.MarketBeat
- Globus Medical Inc (GMED) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
GMED
Earnings
- 2/24/26 - Beat
GMED
Sec Filings
- 2/27/26 - Form 4
- 2/25/26 - Form 144
- 2/24/26 - Form 10-K
- GMED's page on the SEC website